Integrating Timing Considerations to Improve Testing Practices
This chapter addresses a different aspect of the use of timing data: it provides a framework for understanding how an examinee's use of time interfaces with time limits to impact both test performance and the validity of inferences made based on test scores. It focuses primarily on examinations that are administered as part of the physician licensure process.
Qual Life Res 27, 1711–1720 (2018)
The US Food and Drug Administration (FDA), as part of its regulatory mission, is charged with determining whether a clinical outcome assessment (COA) is “fit for purpose” when used in clinical trials to support drug approval and product labeling. This paper provides a review (and some commentary) on the current state of affairs in COA development/evaluation/use with a focus on one aspect: How do you know you are measuring the right thing? In the psychometric literature, this concept is referred to broadly as validity and has itself evolved over many years of research and application.